Why missed payments in lab billing often go undetected and how to capture what is owed.
Most pathology revenue cycle teams have well-defined processes for managing denials, but far fewer have the same level of visibility into missed reimbursement.
That gap matters.
Denied claims are easy to identify, but partially paid claims are not. A denial triggers a clear follow-up action, while a short-paid CPT line can pass through as resolved unless there is a way to compare actual reimbursement against expected reimbursement and flag the variance.
This is what makes missed reimbursements so damaging. They do not always prevent payment, but over time they can quietly chip away at margins without drawing attention.
Why underpayments are harder to catch
Denials disrupt the workflow, demanding immediate attention. Missed reimbursements, however, often blend into the background. A claim may appear resolved once payment is posted, even if one or more services were reimbursed below expectation. Without clear visibility into contract variance and a reliable way to compare expected versus actual payment, these discrepancies are easy to overlook.
The result is a common challenge in pathology billing: teams devote significant time to resolving visible denials while quieter reimbursement gaps continue to erode revenue behind the scenes.
Why pathology needs more detailed reimbursement visibility
Pathology claims introduce added complexity, as a single case often includes multiple CPT codes. As a result, reimbursement issues do not always occur at just one level. A claim may be paid overall, while certain CPT lines are underpaid or denied. When performance is evaluated only at the claim level, recurring patterns at the line-item level can easily go unnoticed. This is where more granular visibility becomes critical.
A stronger pathology reimbursement process should make it possible to:
-
Monitor underpayments and denials at the CPT level
-
Understand reimbursement performance at the case level
-
Identify recurring payer patterns
-
See where line-level issues are driving larger revenue leakage
That level of detail helps teams move beyond general follow-up and focus on the specific services, payers, and workflows causing the problem.
Not every appeal deserves the same attention
One of the biggest opportunities in pathology revenue cycle is not simply working more appeals. It is working the right appeals.
When missed reimbursements are identified, the next step should not default to unstructured, manual review. A more effective approach is to route these issues quickly into a defined workflow, gather the necessary information, and focus team efforts on the variances that offer the greatest return.
That could mean prioritizing by:
-
Payer
-
CPT code
-
Dollar value
-
Case type
-
Recurring variance pattern
-
Appeal success potential
Why contract variance monitoring matters
If your team cannot compare actual payment with expected reimbursement, it becomes difficult to determine whether a claim labeled as “paid” was reimbursed correctly.
This is where contract variance monitoring plays a critical role. It shifts reimbursement from a passive outcome to a measurable, accountable process. Rather than asking only whether a claim was paid, teams can assess whether payment met expectations and quickly identify where variances require attention.
For pathology organizations, this level of visibility is increasingly important as payer behavior becomes more complex and reimbursement pressures continue to intensify.
The opportunity is bigger than denial management
Denial management will always be important, but organizations that want stronger financial performance need to look beyond denials alone.
They need the ability to identify missed reimbursements quickly, route them into the right workflows, and understand where appeal efforts will deliver the greatest return. Just as important is visibility at both the case level and the CPT line level, along with a reimbursement process designed to surface gaps rather than accept them as part of normal operations.
Denials draw attention. Missed reimbursements drive the real impact.
If your team has strong denial processes but limited visibility into contract variance or line-level reimbursement patterns, this may be the next opportunity to address. The foundation is simple: clarity into whether reimbursement meets expectation, not just completion.
